ONE AND DONE
Live / Applied — First extension granted (statement of use) (as of 23 Dec 2025)
What this means for you
Not registered yet, but its 17 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98755607
- Mark type
- Stylized text
- Filed
- 17 Sept 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Deborah L. Lively
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, single-administration genetically engineered pharmaceutical preparations used in the treatment of ocular diseases
Owner
- Adverum Biotechnologies, Inc., Redwood City, CA, US
- Adverum Biotechnologies, Inc., Redwood City, CA, US
Prosecution history
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — ITU LETTER MAILED, NO RESPONSE REQUIRED
- 23 Dec 2025 — SOU EXTENSION 1 GRANTED
- 25 Jul 2025 — SOU EXTENSION 1 FILED
- 23 Dec 2025 — CORRECTED NOA E-MAILED
- 23 Dec 2025 — DIVISIONAL PROCESSING COMPLETE
- 25 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 20 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED